|
| Status |
Public on Feb 16, 2018 |
| Title |
Chemoprevention with COX2 and EGFR inhibition in FAP patients: mRNA signatures of duodenal neoplasia |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
RNA sequencing of duodenal polyps in FAP patients treated with plabebo or the drug combination, erlotinib + sulindac
|
| |
|
| Overall design |
69 duodenal RNA sequencing datasets (17 baseline uninvolved from 17 FAP patients, 10 endpoint uninvolved and 16 polyp from 10 FAP patients on placebo, 10 endpont uninvolved and 16 polyp from 10 FAP patients on drug)
|
| |
|
| Contributor(s) |
Delker D, Neklason D |
| Citation(s) |
29109117 |
| |
| Submission date |
Feb 15, 2017 |
| Last update date |
May 15, 2019 |
| Contact name |
Don Delker |
| E-mail(s) |
don.delker@hsc.utah.edu
|
| Organization name |
University of Utah
|
| Department |
School of Medicine
|
| Street address |
30 North 1900 East
|
| City |
Salt Lake City |
| State/province |
Utah |
| ZIP/Postal code |
84132 |
| Country |
USA |
| |
|
| Platforms (1) |
| GPL16791 |
Illumina HiSeq 2500 (Homo sapiens) |
|
| Samples (69)
|
|
| Relations |
| BioProject |
PRJNA374861 |
| SRA |
SRP099844 |
Less...
More...